The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations. - Wei, Qianqian; Tan, Yuyan; Xu, Pingyi; Tao, Enxiang; Lu, Zuneng; Pan, Xiaoping; Wang, Baojun; Liu, Chunfeng; Dong, Xueshuang; Tian, Yuling; Sun, Xin; Cattaneo, Carlo; et al. (CNS Drugs, 2022)